Bessemer Group’s Mural Oncology MURA Stock Holding History

Bessemer Group’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11	Closed	–	–	2634
2025 Q2	$0	Hold	11	–	–	﹤0.01%	2558
2025 Q1	$0	Buy	11 +2	+22%	+$7	﹤0.01%	2629
2024 Q4	$0	Buy	+9	New	+$32	﹤0.01%	2600

Other funds holding MURA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Bessemer Group's MURA Position: Q3 2025 in Review

Bessemer Group sold out of Mural Oncology (MURA) in Q3 2025, closing a stake of 11 shares.

Bessemer Group first reported a position in MURA in Q4 2024 and held it in 3 quarters. The position peaked at $0 in Q2 2025. 61 funds tracked by Wall St. Rank hold MURA as of Q3 2025.

Bessemer Group reported no remaining Mural Oncology position as of Q3 2025 after selling out during the quarter.
Bessemer Group sold 11 Mural Oncology shares in Q3 2025.
Bessemer Group first reported a position in Mural Oncology in Q4 2024 and held it in 3 quarters.
Bessemer Group's Mural Oncology position peaked at $0 in Q2 2025.
61 funds tracked by Wall St. Rank held Mural Oncology as of Q3 2025.

Based on Bessemer Group's 13F filing for Q3 2025, filed 5 Nov 2025.